ANGLE plc: Angle PLC Announces Update on submission for FDA clearance
ANGLE plc: Angle PLC Announces Update on submission for FDA clearance UPDATE ON SUBMISSION FOR FDA CLEARANCE OF THE PARSORTIX SYSTEM Additional Information Request received from FDA as expected and ANGLE response being prepared in line with expected timescales FDA has indicated its review processes for non COVID-19 devices are currently slower than usual due to COVID-19 pandemic priorities GUILDFORD, SURREY / ACCESSWIRE / March 4, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that, following substantive review of ANGLE's FDA submission requesting De...
Source: finanznachrichten.de